Media Centre

PHASE Scientific Showcases End-to-End “Screen–Diagnose–Treat” Solution at CSCCP 2026 to Help Close Cervical Cancer Screening Gaps

May 18, 2026

PHASE Scientific Announces U.S. FDA CLIA Waiver for FebriDx®

March 27, 2026

Empowering Women’s Health Through Technology

March 12, 2026

PHASE Scientific Expands Cervical Health Portfolio with Exclusive China Distributorship of Liger Medical’s Portable Cervical Treatment

February 5, 2026

PHASE Scientific Shines at IPVS 2025 with Breakthrough Urine-Based HPV Research

October 28, 2025

PHASE Scientific Launches World's Largest Urine-Based Cervical Cancer (HPV) Screening Clinical Study

September 22, 2025